Bulk Price Outlook for (1S)-1-[3,5-Bis(Trifluoromethyl)Phenyl]Ethanol in 2026
- Global demand for enantiopure fluorinated intermediates like (1S)-1-[3,5-bis(trifluoromethyl)phenyl]ethanol is rising due to expanded use in CNS drug pipelines.
- Industrial purity ≥98% and ee ≥99% are now baseline requirements for GMP-compliant API synthesis, directly impacting bulk cost structures.
- Strategic partnerships with integrated manufacturers offer the most stable 2026 bulk pricing amid volatile fluorochemical feedstock markets.
The year 2026 marks a pivotal moment for procurement professionals sourcing high-value chiral building blocks such as (1S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol. With its CAS number 225920-05-8 and alternative nomenclature (αS)-α-Methyl-3,5-bis(trifluoromethyl)benzenemethanol, this compound has become indispensable in asymmetric synthesis routes targeting next-generation therapeutics. As global supply chains recalibrate post-2025, understanding current bulk price dynamics—driven by synthesis complexity, regulatory compliance, and raw material volatility—is essential for cost-efficient scale-up.
Current Bulk Pricing Trends for High-Purity Chiral Intermediates in 2026
Market analysis indicates that bulk prices for enantiomerically enriched (1S)-1-[3,5-bis(trifluoromethyl)phenyl]ethanol have stabilized between USD $1,800–$2,400 per kilogram for multi-kilogram orders (≥10 kg) with industrial purity ≥98% and enantiomeric excess (ee) ≥99%. This range reflects tightened quality standards across North America, Europe, and Asia-Pacific regulatory zones. Notably, prices below $1,700/kg often correlate with compromised COA data—particularly inconsistent residual solvent profiles or sub-98% GC purity—posing significant risk in regulated API manufacturing.
NINGBO INNO PHARMCHEM CO.,LTD., as a premier global manufacturer, maintains competitive 2026 bulk pricing through vertically integrated production of key precursors like 3,5-bis(trifluoromethyl)benzaldehyde. Their in-house control over the asymmetric reduction step—using proprietary chiral catalysts—ensures consistent ee values while minimizing batch-to-batch variability, a critical factor in long-term supply agreements.
Factors Influencing (1S)-1-[3,5-Bis(trifluoromethyl)Phenyl]Ethanol Bulk Costs
Three primary technical and commercial variables dictate bulk pricing for this fluorinated chiral alcohol:
1. Synthesis Route Efficiency
The standard manufacturing process involves enantioselective reduction of 3,5-bis(trifluoromethyl)acetophenone. Traditional routes using stoichiometric chiral reagents yield high ee but generate significant waste, inflating costs. In contrast, NINGBO INNO PHARMCHEM CO.,LTD. employs a catalytic asymmetric hydrogenation route that achieves >99% ee with E-factors under 15, reducing both environmental impact and unit cost.
2. Industrial Purity & Analytical Documentation
Buyers increasingly require full regulatory support packages, including Certificates of Analysis (COA), spectral data (¹H/¹⁹F NMR, HPLC), and residual metal reports. Compounds labeled “≥98%” without validated chiral HPLC methods may fail audit scrutiny. NINGBO INNO PHARMCHEM’s standard COA includes chiral GC validation, water content (KF), and heavy metals (ICP-MS), aligning with ICH Q3 guidelines.
3. Fluorochemical Feedstock Volatility
Trifluoromethyl-containing aromatics remain subject to price swings due to limited global production capacity for hexafluorobenzene derivatives. Strategic inventory management and long-cycle production planning—practiced by integrated players like NINGBO INNO PHARMCHEM—mitigate these fluctuations, offering more predictable 2026 bulk contracts.
How to Source Cost-Effective Quantities Without Compromising Purity or ee%
For pharmaceutical and fine chemical enterprises scaling up clinical candidates, balancing cost and quality requires a vendor capable of both technical excellence and commercial flexibility. Key procurement strategies include:
- Requesting pilot batches with full COA before committing to metric-ton volumes to verify industrial purity and stereochemical integrity.
- Negotiating tiered pricing based on annual volume commitments (e.g., 50 kg vs. 500 kg), which can reduce per-kg costs by 15–25%.
- Validating synthesis route transparency—reputable manufacturers disclose whether resolution or asymmetric synthesis was used, as the latter ensures superior scalability and lower genotoxic impurity risk.
When sourcing high-purity (1S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol, buyers should prioritize suppliers with cGMP-aligned documentation and proven experience in fluorinated chiral intermediates. NINGBO INNO PHARMCHEM CO.,LTD. meets these criteria through ISO 9001-certified facilities and dedicated R&D teams optimizing every stage of the manufacturing process.
Comparative Bulk Pricing & Specification Overview (2026)
| Specification Parameter | Industry Standard | NINGBO INNO PHARMCHEM Offering |
|---|---|---|
| Chemical Name | (1S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol | (1S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol |
| CAS Number | 225920-05-8 | 225920-05-8 |
| Industrial Purity (GC) | ≥98% | ≥99% |
| Enantiomeric Excess (ee) | ≥98% | ≥99.5% |
| Bulk Price Range (≥10 kg) | $1,800–$2,600/kg | $1,750–$2,200/kg |
| COA Includes Chiral Validation? | Often optional | Yes, standard |
| Synthesis Route | Mixed (resolution or catalytic) | Catalytic asymmetric hydrogenation |
In summary, the 2026 bulk market for (1S)-1-[3,5-bis(trifluoromethyl)phenyl]ethanol rewards informed sourcing decisions grounded in technical due diligence. With applications spanning pharmaceutical development, agrochemical innovation, and advanced materials, this chiral intermediate demands a supplier who masters both synthetic chemistry and commercial reliability. NINGBO INNO PHARMCHEM CO.,LTD. stands out as a trusted global manufacturer delivering consistent industrial purity, transparent synthesis routes, and competitive bulk pricing aligned with evolving regulatory expectations.